January 17, 2018
Advancing Careers with Clinical Education, Product and Industry News, Market Research and Wound Care Jobs
Critical/Severe Limb Ischemia Assessment Made Easy

Sponsors
Clinical Webcasts
Lewes, Delaware, 1/5/2018
In The News

Mirragen, developed by Missouri Science and Technology student and ceramic engineer Steve Jung, is a bioactive resorbable glass fiber technology that has been found to help wounds heal faster. As a glass fiber, Mirragen can also be used for wounds with challenging geometries. Bioactive glass has been used since the 1960s to grow bone tissue. The silica used in bioactive glass was not a suitable product for growing soft tissue, but Jung used boron in a glass fiber that was found to help heal soft tissue. The borate-based fiber is sturdy and durable for a period of time, but it also breaks down and dissolves as soft tissue heals. 

The FDA has permitted the marketing for the first shock-wave device for the use of treating diabetic foot ulcers, according to an agency press release. The device is intended for treatment of chronic, full-thickness diabetic foot ulcers with wound areas no larger than 16 cm2 extending through the epidermis, dermis, tendon or capsule, without bone exposure. The device is an external system that employs pulses of energy to stimulate the wound and is intended for use in adults aged at least 22 years with diabetic foot ulcers of more than 30 days’ duration. The device should be used along with standard care.
A new study describes novel probes that enable non-invasive, non-destructive, direct monitoring of the differentiation of mesenchymal stem cells (MSCs) in real-time during the formation of engineered cartilage to replace damaged or diseased tissue. These molecular probes make it possible to assess the quality of the cartilaginous tissue and its suitability for implantation as it is forming, and to make modifications to enhance the multi-step process of MSC differentiation into chondrocytes "on the go".

A recent study conducted at the University of Tampere, Tampere University of Technology, Pirkanmaa Hospital District and Fimlab in Finland has concluded that an electronic nose (eNose) can be used to identify the most common bacteria causing soft tissue infections. A recent study conducted at the University of Tampere, Tampere University of Technology, Pirkanmaa Hospital District and Fimlab in Finland has concluded that an electronic nose (eNose) can be used to identify the most common bacteria causing soft tissue infections. 

A relatively inexpensive egg-based formula and a Star Trek-like plasma patch can accelerate healing of serious and chronic wounds. Inspired in part by Star Trek, his favourite show, Dr. Mahrenholz is bringing the sci-fi use of plasma closer to reality by developing an active plasma dressing for treating chronic wounds. But he warns that the current issues we are experiencing with multidrug-resistant bacteria means that we are on the brink of a return to the Middle Ages in terms of our susceptibility to infection.

 Click Here to view more Wound Care News
Market Research
© 2018 3S Consulting Group, Inc., All rights reserved
This communication is provided by 3S Consulting Group, Inc. as a general information service to our colleagues and friends in the Wound Care Community. It should not be construed as, and does not constitute, an endorsement of the statements or views expressed by parties other than 3S Consulting Group, Inc. or our affiliates. Additional terms and conditions and information are available at www.3SConsultingGroup.com.

The WOC Skin Health Weekly® is a registered trademark of 3S Consulting Group, Inc.